Position in SNY
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$328,491
-$636,109 QoQ
Shares Held
6,818
-65.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Bulltick Wealth Management, LLC holds $5,539,170 across 8 Drug Manufacturers - General names. SNY ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
86,030 | $3,161,602 | |
| 2 | PFE |
Pfizer Inc
|
22,859 | $641,880 | |
| 3 | ABBV |
AbbVie Inc.
|
1,721 | $374,300 | |
| 4 | LLY |
ELI LILLY & Co
|
364 | $334,796 | |
| 5 | SNY |
Sanofi
This page
|
6,818 | $328,491 | |
| 6 | JNJ |
Johnson & Johnson
|
1,334 | $326,082 | |
| 7 | GSK |
GSK plc
|
3,693 | $203,816 | |
| 8 | GRFS |
Grifols SA
|
20,973 | $168,203 |
All Filings in SNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $328,491 | 6,818 | Shares | Sole | 2026-04-27 | |
| 2024-12-31 | $964,600 | 20,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,152,600 | 20,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,911,200 | 60,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,465,896 | 112,467 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||